Top Markets
Coin of the day
Celadon Pharmaceuticals Plc Celadon Pharmaceuticals Plc

Celadon Pharmaceuticals Plc

CEL
Clasificación en acciones #40708
Celadon Pharmaceuticals Plc functions as a drug development company,... Celadon Pharmaceuticals Plc functions as a drug development company, concentrating on the discovery, production, and distribution of cannabinoid compounds for certified medical uses. The firm's primary activity involves the indoor, hydroponic cultivation of THC cannabis, which is then incorporated into medicinal products targeting chronic pain. Furthermore, Celadon intends to broaden its research into cannabinoids, exploring their therapeutic applications not only for persistent pain but also for conditions such as autism and multiple sclerosis. Established in 2018, the company maintains its headquarters in London, United Kingdom.
Precio por acción
$0.00179028
Última sincronización: 2025-07-28
Capitalización bursátil
$94.61K
Cambio (1 día)
-0.54%
Cambio (1 año)
0.00%
País
GB
Comercio Celadon Pharmaceuticals Plc (CEL)

Categoría

Ganancias de Celadon Pharmaceuticals Plc (CEL)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Celadon Pharmaceuticals Plc, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Celadon Pharmaceuticals Plc desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras